Cardiac rhythm management is a specialty function of cardiology which is involved in looking at heart rhythm disorders. It is a branch of cardiology which studies and monitors the heart rhythm to find out any disorders and suggest treatment of cardiac electrophysiology (the electrical conduction and disturbances of the heart) also referred to as Clinical cardiac electrophysiology. With technological advancement cardiac rhythm management function is performed through devices. These devices are used to provide therapeutic solutions to patients suffering from cardiac disorders such as cardiac arrhythmia, atrial fibrillation, heart failure, and cardiac arrests leading to irregular heartbeat.
These devices can detect early symptoms and prevent maximum invasive procedures like bypass surgery also known as coronary artery bypass graft (CABG). Detected symptoms can be cured by cardiac or heart ablation (destroying or scarring of faulty tissues or electrical pathways from sections of the heart) and sometimes aortic valve surgery (removal or replacement of valves). Increasing population with cardiac diseases and cardiothoracic surgery, and growing penetration of such devices with advanced technology in healthcare system are some of the major driving factors for cardiac rhythm management market.
This report identifies the
cardiac rhythm management market size in for the year 2014-2016, and forecast of the same for the year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing consolidated data in relevance to the market drivers, industry insights, restraints, growth indicators, future outlook, dynamic market trends, challenges, competitive landscape, and other key aspects with respect to cardiac rhythm management market.
Globally North America dominated the market share for cardiac rhythm management in 2015 due to improved and advanced healthcare infrastructure, rise in incidences of cardiac disorders, cardiac arrhythmia, cardiothoracic surgery, growing number people with of cardiovascular diseases, and higher healthcare expenditure in the region. North America is forecasted through acute analysis to continue its domination and surge in value chain during the period of study followed by Europe and Asia-Pacific as the second and third largest markets respectively in 2015. However Asia-Pacific is expected to be the fastest growing market due to rapidly changing healthcare infrastructure, increasing medical tourism, increased healthcare expenditure in many developing economies.
This report on global cardiac rhythm management also covers different type of devices available for cardiac rhythm management, end-users of devices and market size in various geographical regions.
- On the basis of cardiac rhythm management device types, this report is classified as follows covering all the major types of devices for cardiac rhythm management: Defibrillators (Implantable Cardioverter Defibrillator (ICD), Non Implantable Cardioverter Defibrillator (NICD) and Cardiac Resynchronization Therapy Defibrillator (CRT-D)), Pacemakers (Single Chamber Pacemakers, Dual Chamber Pacemakers and Cardiac Resynchronization Therapy Pacemaker (CRT-P)) and Implantable Loop Recorder. MCT or Mobile Cardiac Telemetry devices are also a part of device type classification.
- On the basis of end-use segments, this report on cardiac rhythm management is segmented as follows covering all major end-use segments of such devices: Hospitals, Home/Ambulatory and Others. Hospitals have accounted for the largest market share.
- This report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for cardiac rhythm management in each of the region.
Sample Companies Profiled in this Report are:
- Boston Scientific Corporation
- Abbott Laboratories
- St. Jude Medical Inc
- Philips Healthcare
- GE Healthcare